000 01388 a2200385 4500
005 20250512034724.0
264 0 _c19871022
008 198710s 0 0 eng d
022 _a0889-2229
024 7 _a10.1089/aid.1987.3.115
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVolberding, P
245 0 0 _aTherapy of acquired immune deficiency syndrome with recombinant interleukin-2.
_h[electronic resource]
260 _bAIDS research and human retroviruses
_c1987
300 _a115-24 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAcquired Immunodeficiency Syndrome
_xcomplications
650 0 4 _aAntigens, Differentiation, T-Lymphocyte
650 0 4 _aAntigens, Surface
_xanalysis
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Evaluation
650 0 4 _aHumans
650 0 4 _aInterleukin-2
_xadverse effects
650 0 4 _aLeukocyte Count
650 0 4 _aOpportunistic Infections
_xcomplications
650 0 4 _aRecombinant Proteins
_xtherapeutic use
650 0 4 _aSarcoma, Kaposi
_xcomplications
650 0 4 _aT-Lymphocytes
_ximmunology
700 1 _aMoody, D J
700 1 _aBeardslee, D
700 1 _aBradley, E C
700 1 _aWofsy, C B
773 0 _tAIDS research and human retroviruses
_gvol. 3
_gno. 2
_gp. 115-24
856 4 0 _uhttps://doi.org/10.1089/aid.1987.3.115
_zAvailable from publisher's website
999 _c3119258
_d3119258